Goldman Sachs’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,300
Closed -$61K 6101
2017
Q4
$61K Sell
1,300
-800
-38% -$39.6K ﹤0.01% 5891
2017
Q3
$106K Sell
2,100
-1,100
-34% -$51.2K ﹤0.01% 6041
2017
Q2
$159K Buy
3,200
+1,600
+100% +$74.8K ﹤0.01% 5917
2017
Q1
$68K Sell
1,600
-200
-11% -$8.85K ﹤0.01% 6203
2016
Q4
$73K Sell
1,800
-200
-10% -$7.73K ﹤0.01% 6274
2016
Q3
$76K Buy
2,000
+1,600
+400% +$50.7K ﹤0.01% 6341
2016
Q2
$12K Buy
+400
New +$10.5K ﹤0.01% 6828
2016
Q1
Sell
-1,700
Closed -$43K 7175
2015
Q4
$43K Sell
1,700
-1,600
-48% -$49.2K ﹤0.01% 6616
2015
Q3
$98K Buy
+3,300
New +$104K ﹤0.01% 6492

Other funds holding HQY

Goldman Sachs's HQY Position: Q1 2026 in Review

Goldman Sachs reduced its HealthEquity (HQY) stake by 13% in Q1 2026, selling an estimated $10.1M and leaving 800,818 shares worth $66.9M. The position accounts for 0.01% of the portfolio, ranked #1340.

Goldman Sachs first reported a position in HQY in Q3 2014 and has held it in 46 quarters since. The position peaked at $107M in Q4 2024. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Goldman Sachs held 800,818 shares of HealthEquity worth $66.9M as of Q1 2026.
  • Goldman Sachs sold 123,431 HealthEquity shares in Q1 2026, an estimated $10.1M.
  • HealthEquity made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1340 holding.
  • Goldman Sachs first reported a position in HealthEquity in Q3 2014 and has held it in 46 quarters since.
  • Goldman Sachs's HealthEquity position peaked at $107M in Q4 2024.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.